Tizanidine hydrochloride
- Product NDC
- 71209-066
- 11-digit product format
- 712090066
- Labeler code
- 71209
- Product ID
- 71209-066_6edcd49b-7ddf-4ca2-9946-6f1ff6bf22e1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Cadila Pharmaceuticals Limited
- Application
- ANDA210021
- Marketing category
- ANDA
- Marketing start
- 2017-12-29
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 6 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tizanidine hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TIZANIDINE HYDROCHLORIDE | 6 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | B53E3NMY5C |
| Rxcui | 485484, 485485, 485486 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71209-066-07 | Tizanidine hydrochloride | 150 in 1 BOTTLE | CAPSULE | 150 | | 8 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71209-066 | TIZANIDINE HYDROCHLORIDE CAPSULE [CADILA PHARMACEUTICALS LIMITED] | 8 | Current NDC, Legacy NDC, 1 package rows | 20241228_f2f4e117-0318-4bbd-aaa7-fab803714f21.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71209-066-07 | 71209006607 | 150 CAPSULE in 1 BOTTLE (71209-066-07) | 150 capsule | 2017-12-29 | 0000-00-00 | No | No | Current |